Toksoz to sell Turkish generic drug maker Sanovel
Sources close to the matter have been quoted by Reuters as saying that Toksoz has employed JP Morgan Chase, Istanbul-based Alpacar Associates and US boutique adviser Greenhill to
Swedish Orphan Biovitrum (Sobi) has received a complete response letter from the US Food and Drug Administration (FDA) regarding its biologics licence application for nanoencapsulated sirolimus plus pegadricase (NASP), an investigational therapy intended for adults with uncontrolled gout.
The company, which specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), has installed a series of equipments at the centre,
AriBio CEO and president Dr Soo-Hyun Sung said, "This agreement recognizes AriBio’s capabilities in drug discovery and development for ophthalmologic disorders." Both parties have agreed to complete the